Therapy News and Research

RSS

Finding ways to stop cancer at its roots

Why do some cancers come back? Sometimes, a treatment can effectively eliminate cancer cells to undetectable levels, but, if the treatment stops, cancer may return.

7 Nov 2019

Study sheds light on potential strategy for treating Charcot-Marie-Tooth

An unexpected finding from the Scripps Research laboratory of Xiang-Lei Yang, PhD, has illuminated a potential strategy for treating the inherited neurological disease Charcot-Marie-Tooth (CMT), for which there is no approved medicine today.

7 Nov 2019

Liposomes cross blood brain barrier, could get healing drugs to stroke-affected brain

A new study from University of Manchester researchers, published in ACS Neuro, shows a high possibility of treating stroke patients using very small cell sacs called liposomes to bypass the blood brain barrier and carry lifesaving drugs to the brain to prevent damage following a stroke.

7 Nov 2019

Study assesses how geriatric assessment can influence cancer care for vulnerable older people

A Wilmot Cancer Institute-led study in JAMA Oncology shows that when physicians fully appreciate the concerns of older adults with cancer, such as function and forgetfulness, it elevates patient care and satisfaction.

7 Nov 2019

Improved gene editing technique can successfully cut out undesirable genetic information

City of Hope researchers may have found a way to sharpen the fastest, cheapest and most accurate gene editing technique, CRISPR-Cas9, so that it can more successfully cut out undesirable genetic information.

7 Nov 2019

Study uncovers how cells 'forget their past' while developing into a specific cell

All cells in the body contain the same genetic material. The difference between cells therefore depends solely on which genes are expressed or ‘turned on’.

7 Nov 2019

New molecule can reduce aggressiveness of embryonal central nervous system tumors

In Brazil, scientists affiliated with the Human Genome and Stem Cell Research Center (HUG-CELL) at the University of São Paulo (USP) have identified a molecule capable of reducing the aggressiveness of embryonal central nervous system tumors.

7 Nov 2019

New model could predict response of HIV-infected individuals to cancer immunotherapy

A group of researchers at UPF and the Marchuk Institute of Numerical Mathematics in Moscow, Russia, have designed a mathematical model to predict the response of HIV-infected individuals to a type of cancer immunotherapy.

7 Nov 2019

A rare diagnosis leads to successful treatment for patient with unusual vascular condition

Drew, a 65-year-old man from Connecticut, was living an adventurous life until he started to experience unusual muscle weakness in his legs and unexplained fatigued. What he thought was possibly Lyme disease, or symptoms of normal aging, turned out to be much more serious.

7 Nov 2019

UK military researcher studies ways to prevent chronic pain

Josh Van Wyngaarden grew up in a military family, traveling all over the world during his father's 22 years in the Air Force.

7 Nov 2019

Hitachi and CLB establish new research laboratory to improve diagnosis, treatment of cancer

Hitachi, Ltd. and Centre Leon Berard, a leading French Comprehensive Cancer Center in Lyon-France, announced today that they have entered into an agreement to jointly promote research and development aimed at improving the efficiency of diagnosis and treatment of cancer and established a new research laboratory called Hitachi Lyon Lab on the CLB site, starting November 5th.

6 Nov 2019

HIV-1 virus characteristics can predict treatment efficacy with specific antibody treatment

Current HIV-1 therapies have been proven to be highly effective in slowing the progression of the virus in the body with only minimal side effects.

6 Nov 2019

Early sound exposure can help treat hypersensitivity to noise associated with FXS

A research team at the University of California, Riverside, has found exposure to sound -- not sound reduction -- during early development of mice engineered to have Fragile X Syndrome, or FXS, restores molecular, cellular, and functional properties in the auditory cortex, the area of the brain that processes sounds.

6 Nov 2019

MD Anderson, Artios Pharma and ShangPharma collaborate for ATR inhibitor program

The University of Texas MD Anderson Cancer Center, Artios Pharma Limited and ShangPharma Innovation today announce the in-licensing by Artios of a small-molecule ATR inhibitor program, developed jointly by MD Anderson and ShangPharma.

6 Nov 2019

Using high-resolution X-ray analysis to solve structure of stress proteins from Staphylococcus

Project leader, Head of Structural Biology Lab Konstantin Usachev explains, One of the main factors favoring a microorganism's survival in extreme conditions is preserving ribosomes - a macromolecular complex comprising RNA and proteins.

6 Nov 2019

BfR symposium: Current trends and causes of foodborne disease outbreaks

To make food even safer for humans, experts from scientific institutions, food regulatory authorities and the business community will discuss current developments and strategies at the "Zoonoses and Food Safety" Symposium at the German Federal Institute for Risk Assessment) on 4 and 5 November 2019, in Berlin-Marienfelde. Because some micro-organisms in food can cause health problems.

6 Nov 2019

Nanotechnologies can lead to big advances in cancer therapy

Nami Therapeutics Corporation, which gets its name from the Mandarin word for "nano," is committed to using nanotechnologies to make big advances in cancer therapy.

6 Nov 2019

CRISPR-Cas9 protein can help increase targeting accuracy in genome editing process

A team of researchers from City University of Hong Kong and Karolinska Institutet has recently developed a new protein that can help increase the targeting accuracy in the genome editing process. It is believed that it would be useful for future gene therapies in human, which require high precision.

6 Nov 2019

Novel mouse model can help monitor kidney disease progression and perform drug screening

Chronic kidney disease affects 750 million people each year. Aging populations and an increase in diseases such as diabetes will lead to a greater burden of kidney disease.

6 Nov 2019

Gene-editing technique CRISPR trialed for first time as cancer treatment

The go-ahead has been given for the first trials using CRISPR as an alternative therapy for treating cancer.

6 Nov 2019

Therapy News and Research

Finding ways to stop cancer at its roots

Study sheds light on potential strategy for treating Charcot-Marie-Tooth

Liposomes cross blood brain barrier, could get healing drugs to stroke-affected brain

Study assesses how geriatric assessment can influence cancer care for vulnerable older people

Improved gene editing technique can successfully cut out undesirable genetic information

Study uncovers how cells 'forget their past' while developing into a specific cell

New molecule can reduce aggressiveness of embryonal central nervous system tumors

New model could predict response of HIV-infected individuals to cancer immunotherapy

A rare diagnosis leads to successful treatment for patient with unusual vascular condition

UK military researcher studies ways to prevent chronic pain

Hitachi and CLB establish new research laboratory to improve diagnosis, treatment of cancer

HIV-1 virus characteristics can predict treatment efficacy with specific antibody treatment

Early sound exposure can help treat hypersensitivity to noise associated with FXS

MD Anderson, Artios Pharma and ShangPharma collaborate for ATR inhibitor program

Using high-resolution X-ray analysis to solve structure of stress proteins from Staphylococcus

BfR symposium: Current trends and causes of foodborne disease outbreaks

Nanotechnologies can lead to big advances in cancer therapy

CRISPR-Cas9 protein can help increase targeting accuracy in genome editing process

Novel mouse model can help monitor kidney disease progression and perform drug screening

Gene-editing technique CRISPR trialed for first time as cancer treatment

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News